Skip to main content
. 2013 Oct 2;24(4):321–329. doi: 10.3802/jgo.2013.24.4.321

Fig. 3.

Fig. 3

Kaplan-Meier estimates of postrecurrence survival according to the serum squamous cell carcinoma antigen (SCC-Ag) level in patients with (A) pelvic central, single distant, or lymph node recurrences and (B) pelvic sidewall or multiple recurrences. Kaplan-Meier estimates of postrecurrence survival according to salvage treatment in patients with (C) serum SCC-Ag levels<14.0 ng/mL and (D) serum SCC-Ag levels ≥ 14.0 ng/mL.